Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Annette Whitney

Pediatric Gastroenterology Dallas, TX Medical Doctor

NPI 1851351555 CMS profile 310580

7777 Forest Ln, Suite B304, Dallas, TX 75230

Open in the dashboard

General payments

$3,629

144 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$25,037

4 holdings reported · through program year 2025

Research they led as principal investigator

$3,900 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Annette Whitney of Dallas, TX is reported in the CMS Open Payments database as having received $3,629 across 144 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $3,900 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $25,037 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 81st percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $451 19
2024 General $451 20
2023 General $1,291 24
2022 General $348 20
2021 General $556 23
2020 General $291 19
2019 General $241 19
2024 Ownership $11,758 1
2023 Ownership $11,758 1
2022 Ownership $739 1
2021 Ownership $783 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Annette Whitney
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Annette Whitney were reported at $451. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Annette Whitney Pediatric Gastroenterology median Middle half National median
2019 $241 $131 $41–$311 $163
2020 $291 $79 $23–$223 $114
2021 $556 $104 $32–$321 $132
2022 $348 $125 $37–$331 $149
2023 $1,291 $169 $55–$440 $160
2024 $451 $196 $73–$563 $164
2025 $451 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cumberland Pharmaceuticals, Inc. $894 13 payments
  2. AbbVie, Inc. $832 50 payments
  3. Genzyme Corporation $508 18 payments
  4. Regeneron Healthcare Solutions, Inc. $464 18 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $227 8 payments
  6. Nestle HealthCare Nutrition Inc. $150 8 payments
  7. Romark Laboratories, LC $122 12 payments
  8. RedHill Biopharma Inc. $108 1 payment
  9. QOL Medical, LLC $92 4 payments
  10. Phadia US Inc. $49 3 payments
  11. Other $181 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,929 143 payments
  2. Consulting Fee $700 1 payment
Products named General payments · program years 2019–2025
  1. KRISTALOSE $894 13 payments
  2. DUPIXENT Immunology $508 18 payments
  3. HUMIRA $403 28 payments
  4. DUPIXENT Inflammation And Immunology $356 13 payments
  5. CREON $258 18 payments
  6. EOHILIA $142 5 payments
  7. ALINIA Gastroenterology $122 12 payments
  8. ALINIA Gastroenterology $122 12 payments
  9. ALINIA Gastroenterology $122 12 payments
  10. Talicia $108 1 payment
  11. Other $635 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

144 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Gastroenterology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record